Comparative Analysis of Biomarkers in Type 2 Diabetes Patients With and Without Comorbidities: Insights Into the Role of Hypertension and Cardiovascular Disease
Background: Type 2 diabetes mellitus (T2DM) are 90% of diabetes cases, and its prevalence and incidence, including comorbidities, are rising worldwide. Clinically, diabetes and associated comorbidities are identified by biochemical and physical characteristics including glycemia, glycated hemoglobin...
Saved in:
Main Authors: | Symeon Savvopoulos, Haralampos Hatzikirou, Herbert F Jelinek |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2024-02-01
|
Series: | Biomarker Insights |
Online Access: | https://doi.org/10.1177/11772719231222111 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum to “Comparative Analysis of Biomarkers in Type 2 Diabetes Patients With and Without Comorbidities: Insights Into the Role of Hypertension and Cardiovascular Disease”
Published: (2025-02-01) -
Rheumatic Diseases and Obesity: Adipocytokines as Potential Comorbidity Biomarkers for Cardiovascular Diseases
by: Rossana Scrivo, et al.
Published: (2013-01-01) -
Prevalence of Diabetes and Cardiovascular Comorbidity in the Canadian Community Health Survey 20022003
by: Frank Mo, et al.
Published: (2006-01-01) -
Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome
by: Manjula Nandakumar, et al.
Published: (2024-12-01) -
Reverse Dipping of Blood Pressure in Patients of Hypertension with and without Type 2 Diabetes Mellitus
by: Kanwal Shahid, et al.
Published: (2024-12-01)